(toluene-4-sulfonylamino)-methanol | 23666-91-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (toluene-4-sulfonylamino)-methanol
• 英文别名: N-hydroxymethyl-toluene-4-sulfonamide；N-Hydroxymethyl-toluol-4-sulfonamid；N-Hydroxymethyl-p-toluolsulfonamid；N-(hydroxymethyl)-p-toluenesulfonamide；N-(hydroxymethyl)-4-methylbenzenesulfonamide
• CAS: 23666-91-3
• 化学式: C₈H₁₁NO₃S
• 分子量: 201.246
• InChiKey: RBGJDWWIQLEBFF-UHFFFAOYSA-N

物化性质

• 沸点：
  356.3±52.0 °C(Predicted)
• 密度：
  1.308±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  74.8
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (toluene-4-sulfonylamino)-methanol 在 水 作用下， 以 四氢呋喃 为溶剂， 生成 {[Hydroxymethyl-(toluene-4-sulfonyl)-amino]-methyl}-phosphonic acid dimethyl ester
  参考文献：
  名称：

  Mechanism in organophosphorus chemistry. II. Reaction of trialkyl phosphite esters with N-methylol carboxamides and sulfonamides. Trapping of an intermediate

  摘要：

  DOI：

  10.1021/jo00863a006
• 作为产物：
  描述：

  N-[(tert-butyl-methyl-pyridin-2-ylsilyl)methyl]-4-methylbenzenesulfonamide 在 potassium fluoride 、 双氧水 、 potassium hydrogencarbonate 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 以67%的产率得到(toluene-4-sulfonylamino)-methanol
  参考文献：
  名称：

  定向基团策略实现C（sp 3）–H键芳基化和Si键合甲基的酰胺化

  摘要：

  甲硅烷基甲基官能化为获得各种有机硅烷提供了一种通用而有效的途径。甲硅烷基甲基官能化的传统方法通常涉及甲硅烷基甲基金属或甲硅烷基甲基卤化物。近年来，CH活化策略已成为有机合成中最具吸引力的替代方法之一。我们设想，在甲基硅烷的硅上连接一个配位基团可提供通过定向C–H键官能化修饰甲硅烷基甲基的机会。但是，尽管使用了带有指导基团（DG）的C（sp 2）–H功能化硅系绳，由于硅系绳易于安装和拆卸/修改，这一事实已得到很好的确立，将这一概念应用于C（sp 3）– H功能化尚不完善。在本文中，我们通过使用直接基团策略成功开发了Ir III / Rh III催化的甲硅烷基甲基的C–H键芳基化/酰胺化，这是对苄基硅烷和氨基取代的硅烷最有效的途径。此外，我们证明了硅原子上的吡啶指导基很容易被除去，并且起始原料也可以被有效地回收，这与吡啶结合的C结合甲基的C H官能化方法不同。

  DOI：

  10.1021/acscatal.9b00771

文献信息

• TWO -PHOTON UPCONVERTING DYES AND APPLICATIONS
  申请人：——

  公开号：US20030022105A1

  公开（公告）日：2003-01-30

  The present invention is directed to styryl dyes having the formula: 1 wherein D is an electron donating group; Q is an electron acceptor selected from the group consisting of electron acceptors having the formulae: 2 W is an electron accepting group, R 3 is selected from the group consisting of substituted or unsubstituted alkyl or substituted or unsubstituted aryl moieties, n is an integer from 0 to 4, A, B, and C are substituents of their rings and are each independently selected from the group consisting of alkyl, alkoxy, hydroxyalkyl, sulfoalkyl, carboxyalkyl, and hydrogen, and Y is a counterion and compositions thereof. The dyes and compositions exhibit superior two-photon absorption cross-sections and are useful in two-photon pumped cavity lasing, two-photon pumped up-conversion lasing, optical power limiting, optical power stabilization, optical signal reshaping, and infrared beam detection and indication. The present invention is also directed to a multiphasic nanostructured composite including a glass having pores, an optically active coating material on the pore surface, such as a sytryl dye of the present invention, and a polymeric material in the pores. Optionally, the polymeric material can have a second optically active material dispersed therein. These composites are useful in producing multifunctional optical materials, such as broadly tunable lasers. The present invention is also directed to a method for killing cells and viruses. The method includes providing proximate to the cells or viruses a photosensitizer, such as a porphyrin, and a two-photon upconverting dye, such as a styryl dye of the present invention. The dye is then exposed to light in the presence of oxygen under conditions effective to produce a cytotoxic effect on the cells or viruses. These methods are especially useful to kill cells and viruses in biological materials, such as in photodynamic therapy of tumors and cancers or blood purification protocols. In another aspect, the present invention discloses media and methods for recording data. A three-dimensional matrix including a plurality of dye molecules, such a styryl dye molecule of the present invention, is provided. A first volume element in the matrix is exposed to actinic radiation for a duration and at an intensity effective to alter detectably a fraction between 0.3 and 0.7 of the dye molecules contained therein. The detectably altered dye molecules are substantially uniformly dispersed in the first volume element. The data storage methods and media of the present invention have approximately 10 12 volume elements per square centimeter, and each of the volume elements can store a single bit, digital information of approximately 8 bits, or analog information. The data storage methods and media of the present invention are particularly useful for storing or archiving a series of two-dimensional black and white or color images, such as frames of a movie. Methods for reading data stored in the data storage media of the present invention using confocal microscopy are also disclosed.

  本发明涉及具有以下公式的苯乙烯染料：1其中D为电子供体基团；Q为从具有以下公式的电子受体组成的组中选择的电子受体：2W为电子受体基团；R3从取代或未取代的烷基或取代或未取代的芳基基团组成的组中选择；n为0到4的整数；A、B和C是它们的环的取代基，且每个独立地从烷基、烷氧基、羟基烷基、磺基烷基、羧基烷基和氢中选择；Y为一个计数离子。该染料和组合物表现出优越的双光子吸收截面，并可用于双光子泵浦腔激光、双光子泵浦上转换激光、光功率限制、光功率稳定、光信号重塑和红外光束检测和指示。本发明还涉及一种多相纳米结构复合材料，包括具有孔道的玻璃、孔表面上的光学活性涂层材料，例如本发明的苯乙烯染料，以及孔内的聚合物材料。可选地，聚合物材料中可以分散有第二种光学活性材料。这些复合材料可用于生产多功能光学材料，例如广泛可调谐激光器。本发明还涉及一种杀死细胞和病毒的方法。该方法包括在靠近细胞或病毒的位置提供光敏剂，例如卟啉，以及本发明的苯乙烯染料等双光子上转换染料。然后，在氧气存在的条件下，将染料暴露于光下，以对细胞或病毒产生细胞毒作用。这些方法特别适用于在生物材料中杀死肿瘤和癌症或血液净化协议等细胞和病毒。在另一方面，本发明揭示了用于记录数据的介质和方法。提供了一个三维矩阵，其中包括多个染料分子，例如本发明的苯乙烯染料分子。将矩阵中的第一个体积元素暴露于光化学辐射下，以在0.3和0.7之间改变其中所含的染料分子的分数。经过可检测的改变的染料分子在第一个体积元素中被均匀分散。本发明的数据存储方法和介质每平方厘米有大约1012个体积元素，每个体积元素可以存储一个比特、大约8个比特的数字信息或模拟信息。本发明的数据存储方法和介质特别适用于存储或归档一系列二维黑白或彩色图像，例如电影帧。还揭示了使用共聚焦显微镜读取本发明的数据存储介质中存储的数据的方法。
• Plasticized polymer compositions
  申请人：UCB, S.A.

  公开号：US20020165301A1

  公开（公告）日：2002-11-07

  The invention relates to compositions comprising at least one polymer and at least one plasticizer, in which compositions the polymer is semi-crystalline and exhibits a processing temperature equal to or greater than 220° C., preferably 250° C., and the plasticizer is an aromatic benzenesulphonamide represented by the general formula (I) 1 in which R 1 represents a hydrogen atom, a C 1 -C 4 alkyl group or a C 1 -C 4 alkoxy group, X represents a linear or branched C 2 -C 10 alkylene group, or a cycloaliphatic group, or an aromatic group, Y represents one of the groups OH or 2 R 2 representing a C 1 -C 4 alkyl group or an aromatic group, these groups optionally themselves being substituted by an OH or C 1 -C 4 alkyl group. The aromatic benzenesulphonamides have little volatility and exhibit good thermal stability, which makes it possible to effectively plasticize polyamides which are processed at high temperatures, such as polyamides-6, -6,6, -4,6, -6,9, -6,10, -6,12 and MDX-6 and polyketones, but also polyamides-11 and -12, polyoxymethylene and poly(vinylidene fluoride).

  本发明涉及一种包含至少一种聚合物和至少一种增塑剂的组合物，其中聚合物是半结晶的，处理温度等于或大于220℃，优选为250℃，增塑剂是一种芳香基苯磺酰胺，其通式为（I）： 其中，R1代表氢原子、C1-C4烷基或C1-C4烷氧基；X代表线性或支链状的C2-C10烷基、环状脂肪族基、芳香族基；Y代表OH基或2个R2代表C1-C4烷基或芳香族基，这些基团可以自身被OH基或C1-C4烷基所取代。 这些芳香基苯磺酰胺的挥发性很小，具有良好的热稳定性，可以有效地增塑高温加工的聚酰胺，如聚酰胺-6、-6,6、-4,6、-6,9、-6,10、-6,12和MDX-6以及聚酮，还可以增塑聚酰胺-11和-12、聚甲醛和聚偏氟乙烯。
• COMPOSITIONS AND TREATMENT METHODS-2
  申请人：Frincke James M.

  公开号：US20100222425A1

  公开（公告）日：2010-09-02

  The invention relates to the use of compounds to treat a number of conditions, such as thrombocytopenia, neutropenia or the delayed effects of radiation therapy. Compounds that can be used in the invention include methyl-2,3,4-trihydroxy-1-O-(7,17-dioxoandrost-5-ene-3β-yl)-β-D-glucopyranosiduronate, 16α,3α-dihydroxy-5α-androstan-17-one or 3,7,16,17-tetrahydroxyandrost-5-ene, 3,7,16,17-tetrahydroxyandrost-4-ene, 3,7,16,17-tetrahydroxyandrost-1-ene or 3,7,16,17-tetrahydroxyandrostane that can be used in the treatment method.

  本发明涉及使用化合物治疗多种疾病，例如血小板减少症、中性粒细胞减少症或放射治疗的延迟影响。可以在本发明中使用的化合物包括甲基-2,3,4-三羟基-1-O-(7,17-二氧代雄烯-5-烯-3β-基)-β-D-葡萄糖吡喃糖醇酸酯、16α,3α-二羟基-5α-雄甾烷-17-酮或3,7,16,17-四羟基雄烯-5-烯、3,7,16,17-四羟基雄烯-4-烯、3,7,16,17-四羟基雄烯-1-烯或3,7,16,17-四羟基雄烷。这些化合物可以用于治疗方法中。
• 15-THIA STEROID COMPOUNDS AND COMPOSITIONS
  申请人：Frincke James M.

  公开号：US20110218162A1

  公开（公告）日：2011-09-08

  The invention relates to the use of compounds to treat a number of conditions, such as thrombocytopenia, neutropenia or the delayed effects of radiation therapy. Compounds that can be used in the invention include methyl-2,3,4-trihydroxy-1-O-(7,17-dioxoandrost-5-ene-3β-yl)-β-D-glucopyranosiduronate, 16α,3α-dihydroxy-5α-androstan-17-one or 3,7,16,17-tetrahydroxyandrost-5-ene, 3,7,16,17-tetrahydroxyandrost-4-ene, 3,7,16,17-tetrahydroxyandrost-1-ene or 3,7,16,17-tetrahydroxyandrostane that can be used in the treatment method.

  本发明涉及使用化合物治疗多种疾病，例如血小板减少症、中性粒细胞减少症或放射治疗的延迟效应。可用于本发明的化合物包括甲基-2,3,4-三羟基-1-O-(7,17-二氧代雄烯-5-烯-3β-基)-β-D-葡萄糖吡喃糖醇、16α,3α-二羟基-5α-雄甾酮-17-酮或3,7,16,17-四羟基雄烯-5-烯、3,7,16,17-四羟基雄烯-4-烯、3,7,16,17-四羟基雄烯-1-烯或3,7,16,17-四羟基雄烷，可用于治疗方法。
• MODULATORS OF ATP-BINDING CASSETTE-TRANSPORTERS
  申请人：Hadida Ruah Sara S.

  公开号：US20130296364A1

  公开（公告）日：2013-11-07

  Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.

  本发明的化合物及其药学上可接受的组合物可用作ATP结合盒（“ABC”）转运蛋白或其片段的调节剂，包括囊性纤维化跨膜传导调节因子（“CFTR”）。本发明还涉及使用本发明的化合物治疗ABC转运蛋白介导的疾病的方法。